Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 197


Isolation of early hematopoietic cells, including megakaryocyte progenitors, in the ALDH-bright cell population of cryopreserved, banked UC blood.

Gentry T, Deibert E, Foster SJ, Haley R, Kurtzberg J, Balber AE.

Cytotherapy. 2007;9(6):569-76.


Dual SP/ALDH functionalities refine the human hematopoietic Lin-CD34+CD38- stem/progenitor cell compartment.

Pierre-Louis O, Clay D, Brunet de la Grange P, Blazsek I, Desterke C, Guerton B, Blondeau C, Malfuson JV, Prat M, Bennaceur-Griscelli A, Lataillade JJ, Le Bousse-Kerdilès MC.

Stem Cells. 2009 Oct;27(10):2552-62. doi: 10.1002/stem.186.


The "common stem cell" hypothesis reevaluated: human fetal bone marrow contains separate populations of hematopoietic and stromal progenitors.

Waller EK, Olweus J, Lund-Johansen F, Huang S, Nguyen M, Guo GR, Terstappen L.

Blood. 1995 May 1;85(9):2422-35.


Extended flow cytometry characterization of normal bone marrow progenitor cells by simultaneous detection of aldehyde dehydrogenase and early hematopoietic antigens: implication for erythroid differentiation studies.

Mirabelli P, Di Noto R, Lo Pardo C, Morabito P, Abate G, Gorrese M, Raia M, Pascariello C, Scalia G, Gemei M, Mariotti E, Del Vecchio L.

BMC Physiol. 2008 May 29;8:13. doi: 10.1186/1472-6793-8-13.


Umbilical cord blood-derived aldehyde dehydrogenase-expressing progenitor cells promote recovery from acute ischemic injury.

Putman DM, Liu KY, Broughton HC, Bell GI, Hess DA.

Stem Cells. 2012 Oct;30(10):2248-60. doi: 10.1002/stem.1206.


CD34+CDw90(Thy-1)+ subset colocated with mesenchymal progenitors in human normal bone marrow hematon units is enriched in colony-forming unit megakaryocytes and long-term culture-initiating cells.

Boiret N, Rapatel C, Boisgard S, Charrier S, Tchirkov A, Bresson C, Camilleri L, Berger J, Guillouard L, Guérin JJ, Pigeon P, Chassagne J, Berger MG.

Exp Hematol. 2003 Dec;31(12):1275-83.


Aldehyde dehydrogenase activity allows reliable EPC enumeration in stored peripheral blood samples.

Povsic TJ, Adams SD, Zavodni KL, Kelly F, Melton LG, Rao SV, Najjar SS, Harrington RA, Peterson ED.

J Thromb Thrombolysis. 2009 Oct;28(3):259-65. doi: 10.1007/s11239-009-0306-6.


Bone marrow-derived aldehyde dehydrogenase-bright stem and progenitor cells for ischemic repair.

Keller LH.

Congest Heart Fail. 2009 Jul-Aug;15(4):202-6. doi: 10.1111/j.1751-7133.2009.00101.x. Review.


Immunological and ultrastructural characterization of endothelial cell cultures differentiated from human cord blood derived endothelial progenitor cells.

Neumüller J, Neumüller-Guber SE, Lipovac M, Mosgoeller W, Vetterlein M, Pavelka M, Huber J.

Histochem Cell Biol. 2006 Dec;126(6):649-64.


Characterization of cardiac-resident progenitor cells expressing high aldehyde dehydrogenase activity.

Roehrich ME, Spicher A, Milano G, Vassalli G.

Biomed Res Int. 2013;2013:503047. doi: 10.1155/2013/503047.


Improved purification of hematopoietic stem cells based on their elevated aldehyde dehydrogenase activity.

Christ O, Lucke K, Imren S, Leung K, Hamilton M, Eaves A, Smith C, Eaves C.

Haematologica. 2007 Sep;92(9):1165-72.


Identification of a primitive brain-derived neural stem cell population based on aldehyde dehydrogenase activity.

Corti S, Locatelli F, Papadimitriou D, Donadoni C, Salani S, Del Bo R, Strazzer S, Bresolin N, Comi GP.

Stem Cells. 2006 Apr;24(4):975-85.


Isolation of functionally distinct mesenchymal stem cell subsets using antibodies against CD56, CD271, and mesenchymal stem cell antigen-1.

Battula VL, Treml S, Bareiss PM, Gieseke F, Roelofs H, de Zwart P, Müller I, Schewe B, Skutella T, Fibbe WE, Kanz L, Bühring HJ.

Haematologica. 2009 Feb;94(2):173-84. doi: 10.3324/haematol.13740.


Aldehyde dehydrogenase activity as a marker for the quality of hematopoietic stem cell transplants.

Lioznov MV, Freiberger P, Kröger N, Zander AR, Fehse B.

Bone Marrow Transplant. 2005 May;35(9):909-14.


Aldehyde dehydrogenase activity among primary leukemia cells is associated with stem cell features and correlates with adverse clinical outcomes.

Ran D, Schubert M, Pietsch L, Taubert I, Wuchter P, Eckstein V, Bruckner T, Zoeller M, Ho AD.

Exp Hematol. 2009 Dec;37(12):1423-34. doi: 10.1016/j.exphem.2009.10.001.


Selection based on CD133 and high aldehyde dehydrogenase activity isolates long-term reconstituting human hematopoietic stem cells.

Hess DA, Wirthlin L, Craft TP, Herrbrich PE, Hohm SA, Lahey R, Eades WC, Creer MH, Nolta JA.

Blood. 2006 Mar 1;107(5):2162-9.

Items per page

Supplemental Content

Support Center